ALKBH5 and neuroblastoma: We also validated METTL3 and ALKBH5 binding to ADAMTS9-AS2 in neuroblastoma cells using RIP followed by qRT-PCR and pulldown assays coupled with Western blotting (Figure 6, B and C).